Moderna Inc on Thursday reported stronger-than-expected sales of $1.9 billion for its COVID-19 vaccine in the first quarter, driven by a surge of revenue deferred from 2022, but left its 2023. | May 4, 2023
Indonesia has approved its first domestically-produced COVID-19 vaccine for emergency use for people over 18, the chief of the country s food and drugs agency was quoted by news media as saying. | September 28, 2022
Moderna said on Thursday it has approached the Food and Drug Administration to authorize a second COVID-19 booster shot for everyone 18 and older to address the waning effectiveness of its previous. | March 18, 2022
The World Health Organization said on
Wednesday it has set up a hub in South Korea to train low- and
middle-income countries to produce their own vaccines and
therapies, and is expanding its COVID-19. | February 24, 2022